Global Abdominal Aortic Aneurysm Repair Devices Market Size, and Share, By Product Type (Endografts, Delivery Systems, Ancillary Devices, and Others), By Procedure Type (Open Surgical Repair and Endovascular Aneurysm Repair (EVAR)), By Anatomy (Infrarenal AAA and Pararenal AAA), By End User (Hospitals, Ambulatory Surgical Centres, and Other End Users), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 - 2035.

Global Abdominal Aortic Aneurysm Repair Devices Market Insights Forecasts to 2035

• The Global Abdominal Aortic Aneurysm Repair Devices Market Size Was Estimated at USD 2.83 Billion in 2025
• The Market Size is Expected to Grow at a CAGR of around 6.05% from 2026 to 2035
• The Worldwide Abdominal Aortic Aneurysm Repair Devices Market Size is Expected to Reach USD 5.09 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, the global abdominal aortic aneurysm repair devices market size was worth around USD 2.83 billion in 2025 and is predicted to grow to around USD 5.09 billion by 2035 with a compound annual growth rate (CAGR) of 6.05% from 2026 to 2035. The abdominal aortic aneurysm repair devices market is developing through technologies which include advanced stent graft technologies, AI-driven imaging, expanded screening programs, emerging market developments and customized medical devices.

Market Overview

The worldwide market for abdominal aortic aneurysm (AAA) repair devices involves medical equipment that doctors use to treat dangerous abdominal aorta expansion through traditional open surgery and modern endovascular methods. Hospitals use these devices, which include stent grafts to stop aneurysm rupture, because untreated aneurysms have a mortality rate that exceeds 80-90%. The market expansion results from growing AAA cases, which occur in approximately 2-5% of men aged 65 and above worldwide and the increasing number of elderly people who develop health problems from smoking and hypertension. In October 2024, the NHS published its 2023-2024 AAA screening report, with over 271,000 men screened from 331,000 eligible. Around 2,004 aneurysms were detected, and 810 cases were referred for treatment. The program continues to support early detection, surveillance, and timely intervention to reduce mortality from ruptured aneurysms.

The current market demands endovascular aneurysm repair (EVAR), which has developed into the dominant procedure used in developed countries because it offers patients faster healing times and fewer health risks. Modern surgical methods have adopted next-generation stent grafts and 3D imaging-guided procedures and customized patient-specific devices, which enhance both surgical performance and patient results. The worldwide market growth receives support from both increased healthcare investments and the expansion of screening programs. In December 2025, the Health Information and Quality Authority (HIQA) advised against launching a national AAA screening program, citing a declining prevalence of about 1% among men aged 65. The assessment noted reduced clinical and economic benefits, recommending that resources be redirected toward improving existing vascular care pathways and treatment efficiency.

Report Coverage

This research report categorizes the abdominal aortic aneurysm repair devices market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the abdominal aortic aneurysm repair devices market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the abdominal aortic aneurysm repair devices market. 

Driving Factors

The global abdominal aortic aneurysm (AAA) repair devices market requires advanced imaging technology because hospitals need to complete their surgical procedures at least 25-30% faster than standard operating times. The healthcare spending levels in developed countries, which exceed 9-10% of GDP, help people receive surgical procedures. The world experiences increased surgical capabilities because hospital networks and vascular specialty centers continue to build new facilities. The reimbursement system in North America and Europe supports EVAR procedures through financial incentives. The technological advancements have decreased EVAR procedure mortality rates to below 3%, which has created stronger market demand for advanced repair devices because doctors and patients now prefer these devices.

Restraining Factors                                                                                                

The AAA repair devices market faces restraints because the high procedural costs make EVAR procedures 20-30% more expensive than open surgery. The shortage of qualified vascular surgeons, together with the limited access to medical facilities in developing countries, creates an operational barrier. The medical field faces two main issues because patients develop post-surgical problems and need to undergo another procedure at a rate between 10-20%. The strict regulatory approval process causes delays that affect both product development and market entry.

Market Segmentation

The abdominal aortic aneurysm repair devices market share is classified into product type, procedure type, anatomy, and end user.  

• The endografts segment dominated the market in 2025, approximately 58% and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the abdominal aortic aneurysm repair devices market is divided into endografts, delivery systems, ancillary devices, and others. Among these, the endografts segment dominated the market in 2025 and is projected to grow at a substantial CAGR during the forecast period. The segment growth dominance is attributed to increasing preference for minimally invasive EVAR procedures, which use stent grafts for effective aneurysm exclusion. Benefits such as reduced recovery time, lower surgical risks, and shorter hospital stays drive adoption. Continuous advancements in graft design, durability, and patient-specific customization further enhance clinical outcomes, boosting segment growth globally.

• The endovascular aneurysm repair (EVAR) segment accounted for the largest share in 2025, approximately 69% and is anticipated to grow at a significant CAGR during the forecast period.

Based on the procedure type, the abdominal aortic aneurysm repair devices market is divided into open surgical repair and endovascular aneurysm repair (EVAR). Among these, the endovascular aneurysm repair (EVAR) segment accounted for the largest share in 2025 and is anticipated to grow at a significant CAGR during the forecast period. The segment growth is driven by its minimally invasive nature, reduced operative risks, shorter hospital stays, and faster recovery compared to open surgery. Increasing adoption among elderly patients, growing preference among surgeons, and continuous technological advancements in stent grafts and imaging guidance further accelerate EVAR demand globally.

• The infrarenal AAA segment dominated the market in 2025, approximately 78% and is projected to grow at a substantial CAGR during the forecast period.

Based on the anatomy, the abdominal aortic aneurysm repair devices market is divided into infrarenal AAA and pararenal AAA. Among these, the infrarenal AAA segment dominated the market in 2025 and is projected to grow at a substantial CAGR during the forecast period. The segment dominated the market growth owing to the higher prevalence of aneurysms occurring below the renal arteries, making them more suitable for standard EVAR procedures. Favorable anatomical characteristics, easier surgical access, and wider availability of compatible stent grafts contribute to higher treatment rates. Increasing screening and early diagnosis further support segment growth globally.

• The hospitals segment accounted for the highest market revenue in 2025, approximately 74% and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the abdominal aortic aneurysm repair devices market is divided into hospitals, ambulatory surgical centres, and other end users. Among these, the hospitals segment accounted for the highest market revenue in 2025 and is anticipated to grow at a significant CAGR during the forecast period. The hospitals segment market growth is due to the availability of advanced surgical infrastructure, skilled vascular surgeons, and comprehensive postoperative care. Hospitals handle a high volume of AAA procedures, including complex and emergency cases. Increasing patient admissions, improved reimbursement policies, and access to advanced imaging and endovascular technologies further drive the segment’s growth globally.

Regional Segment Analysis of the Abdominal Aortic Aneurysm Repair Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the abdominal aortic aneurysm repair devices market over the predicted timeframe.

North America is anticipated to hold the 45% share of the abdominal aortic aneurysm repair devices market over the predicted timeframe. The region dominates the abdominal aortic aneurysm repair devices market growth due to advanced healthcare infrastructure, high adoption of minimally invasive EVAR procedures, and the strong presence of leading medical device companies. The United States dominates the region, driven by high AAA prevalence, favorable reimbursement policies, and widespread screening programs, particularly among the aging population. Canada also contributes steadily through government-supported healthcare initiatives and increasing awareness of early diagnosis. Additionally, rising healthcare expenditure, growing adoption of innovative stent graft technologies, and strong regulatory support further strengthen regional market expansion. In September 2025, Ontario launched the Abdominal Aortic Aneurysm Screening Program, Canada’s first, targeting adults aged 65 and older. The initiative offers free ultrasound screening and invites eligible individuals through Ontario Health to promote early detection and prevent life-threatening aneurysm ruptures.

Asia Pacific is expected to grow at a rapid CAGR in the abdominal aortic aneurysm repair devices market during the forecast period. The region is rapidly growing in the abdominal aortic aneurysm repair devices market due to improving healthcare infrastructure, rising awareness, and increasing adoption of minimally invasive EVAR procedures. China leads growth with expanding hospital networks and government healthcare investments, while India benefits from a large aging population and improving access to vascular care. Japan contributes through advanced medical technology and high diagnosis rates. Growing medical tourism and rising healthcare expenditure further accelerate regional market expansion.

Europe’s abdominal aortic aneurysm repair devices market is growing due to strong healthcare systems, a rising aging population, and widespread adoption of minimally invasive EVAR procedures. Germany leads with advanced medical infrastructure and high procedure volumes, while the UK supports growth through national screening programs. France and Italy contribute with increasing healthcare investments and early diagnosis initiatives, further boosting regional demand.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the abdominal aortic aneurysm repair devices market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Medtronic
• L. Gore & Associates
• Cook Medical
• Terumo Aortic
• Endologix LLC
• Cardinal Health
• Artivion, Inc.
• Cardiatis SA
• LifeTech Scientific
• LeMaitre Vascular, Inc.
• Lombard Medical
• Endospan Ltd.
• MicroPort Scientific Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

In April 2026, Artivion announced FDA PMA approval for the NEXUS Aortic Arch System developed by Endospan. The minimally invasive branched endovascular stent graft treats complex aortic arch disease. Clinical trial results showed 90% survival from lesion-related death and strong outcomes, offering an alternative to high-risk open-chest surgery.

In March 2026, Terumo Aortic received FDA Breakthrough Device Designation for its Fenestrated TREO Abdominal Stent-Graft system. The program accelerates review of innovative devices for life-threatening conditions. The custom-made endovascular system targets complex abdominal aortic aneurysms, offering improved anatomical fit and expanding treatment options for high-risk patients.

In October 2025, Medtronic received FDA approval to update labeling for its Endurant stent graft system, removing the warning for ruptured abdominal aortic aneurysm treatment. This makes it the first device approved for such use, providing physicians greater confidence in emergency endovascular procedures for high-risk, life-threatening cases.

In August 2025, Cook Medical and Siemens Healthineers unveiled a fully integrated Interventional MRI (iMRI) Suite at SIR 2026, enabling radiation-free, minimally invasive procedures with advanced imaging and MR-conditional devices. Meanwhile, the ZENITH Fenestrated+ Endovascular Graft clinical study reached its final patient, marking progress in endovascular aneurysm repair innovation and clinical evaluation.

In September 2024, the U.S. focus shifted toward more inclusive AAA screening after a Journal of Vascular Surgery study highlighted gaps in USPSTF guidelines. Only 0.90% of at-risk female smokers were screened, prompting calls for broader clinical judgment beyond existing recommendations to improve early detection and reduce mortality rates.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the abdominal aortic aneurysm repair devices market based on the below-mentioned segments: 

Global Abdominal Aortic Aneurysm Repair Devices Market, By Product Type

• Endografts
• Delivery Systems
• Ancillary Devices
• Others

Global Abdominal Aortic Aneurysm Repair Devices Market, By Procedure Type

• Open Surgical Repair
• Endovascular Aneurysm Repair (EVAR)

Global Abdominal Aortic Aneurysm Repair Devices Market, By Anatomy

• Infrarenal AAA
• Pararenal AAA

Global Abdominal Aortic Aneurysm Repair Devices Market, By End User

• Hospitals
• Ambulatory Surgical Centres
• Other End Users

Global Abdominal Aortic Aneurysm Repair Devices Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa